Cancer letters最新文献

筛选
英文 中文
Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; NrasQ61R mice. Vk*MYC患者的差异骨髓瘤进展及对TIGIT免疫检查点阻断的应答NrasQ61R老鼠。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-11 DOI: 10.1016/j.canlet.2026.218965
Vysakh Anandan, Adhithi Rajagopalan, David Wang, Evan D Flietner, Parth H Khatri, Yun Zhou, Joshua Brand, Jing Li, Erik A Ranheim, Sophie Verbeke, Meher Gayatri Bolisetti, Lucy Chen, Esra'a Keewan, Jacqueline A Cook, Marta Chesi, P Leif Bergsagel, Fotis Asimakopoulos, Huy Q Dinh, Jing Zhang
{"title":"Differential myeloma progression and response to TIGIT immune checkpoint blockade in Vk*MYC; Nras<sup>Q61R</sup> mice.","authors":"Vysakh Anandan, Adhithi Rajagopalan, David Wang, Evan D Flietner, Parth H Khatri, Yun Zhou, Joshua Brand, Jing Li, Erik A Ranheim, Sophie Verbeke, Meher Gayatri Bolisetti, Lucy Chen, Esra'a Keewan, Jacqueline A Cook, Marta Chesi, P Leif Bergsagel, Fotis Asimakopoulos, Huy Q Dinh, Jing Zhang","doi":"10.1016/j.canlet.2026.218965","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218965","url":null,"abstract":"","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218965"},"PeriodicalIF":11.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Immunoprofiling and Multi-Omics Modeling Reveal Key Immune Features Associated with Disease Progression and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma. 综合免疫图谱和多组学模型揭示了与不可切除肝细胞癌患者疾病进展和临床结果相关的关键免疫特征。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-11 DOI: 10.1016/j.canlet.2026.218946
Zhao Yang, Yeye Wu, Xiangjun Ji, Yunshuo Chen, Xia Chen, Wenbo Wang, Wen Wen, Wei Mu, Yang Ge
{"title":"Comprehensive Immunoprofiling and Multi-Omics Modeling Reveal Key Immune Features Associated with Disease Progression and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma.","authors":"Zhao Yang, Yeye Wu, Xiangjun Ji, Yunshuo Chen, Xia Chen, Wenbo Wang, Wen Wen, Wei Mu, Yang Ge","doi":"10.1016/j.canlet.2026.218946","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218946","url":null,"abstract":"<p><p>Comprehensive profiling of peripheral immune cells has shown prognostic and disease-monitoring value across multiple cancers, but its clinical relevance in hepatocellular carcinoma (HCC), particularly unresectable HCC, remains insufficiently defined. To address this gap, we performed integrated peripheral immunoprofiling combining T-cell receptor (TCR) repertoire sequencing, flow cytometry-based T-cell phenotyping, bulk RNA sequencing, and public single-cell RNA-seq analysis in healthy donors, resectable HCC patients, and unresectable HCC patients. This design enabled characterization of HCC-associated and stage-associated peripheral immune alterations and identification of immunotherapy-relevant features in unresectable HCC. Single-cell analysis and flow cytometry revealed remodeling of circulating T-cell states in unresectable HCC, including reduced naïve-like compartments, enrichment of Treg-like cells, and increased memory/effector differentiation. TCR repertoire analysis showed reduced diversity, increased clonal dominance, altered V-J gene usage, decreased interindividual sharing, and convergent motif-level alterations, with early CD4<sup>+</sup> TCR perturbations in resectable HCC and more pronounced CD8<sup>+</sup> repertoire restriction in unresectable disease. Exploratory GLIPH-based motif analysis, HLA inference, and peptide-HLA binding prediction suggested candidate motif-HLA antigen associations involving hepatitis virus-derived antigens and recurrent HCC mutation-derived candidate neoantigens, although experimental validation is required. Bulk RNA-seq of peripheral CD8<sup>+</sup> T cells revealed higher Activation/Effector function, Exhaustion, and Anergy signature scores in both resectable and unresectable HCC than in HDs, with no significant differences between the two HCC groups, whereas the Chemokine/Chemokine receptor signature was specifically increased in unresectable HCC. The overall IFN-response signature did not differ significantly among the three groups. Integrative machine-learning models were then developed using 818 peripheral immune-related features. Among them, the random forest (RF) model effectively distinguished healthy donors, resectable HCC patients, and unresectable HCC patients, with consistently high sensitivity and area under the curve (AUC) in both cross-validation and an independent validation cohort. In unresectable HCC patients receiving immunotherapy, four features derived from TCR-seq and T-cell subset profiling discriminated responders (CR/PR) from non-responders (SD/PD) in univariate analyses, while multivariate prioritization further highlighted ULBP1 as a consistently prioritized response-associated feature that requires validation in an independent cohort. Overall, this study supports comprehensive peripheral immune profiling as an exploratory framework for identifying stage-associated immune alterations and candidate biomarkers to inform personalized immunotherapy strategies in HCC.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218946"},"PeriodicalIF":11.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CIP2A drives lung adenocarcinoma by activating mitochondrial respiratory complexes IV and V. CIP2A通过激活线粒体呼吸复合体IV和V驱动肺腺癌。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-11 DOI: 10.1016/j.canlet.2026.218967
Fu-Ying Yang, Di Wang, Liu Ye, Yi-Meng Zhang, Li-Jun Liang, Yan-Fei Zhang, Yi-Shuai Tan, Aikede Alifu, Meng-Yao Lv, Fen-Rong Xie, Yan-Yun Gao, Jiao-Jiao Xu, Yang-Tong Liu, Cong Wang, Bing-Qing Xu, Yan-Zhi Bai, Zhi-Xiao Liao, Yu-Tao Liu, Gui-Zhen Wang, Guang-Biao Zhou
{"title":"CIP2A drives lung adenocarcinoma by activating mitochondrial respiratory complexes IV and V.","authors":"Fu-Ying Yang, Di Wang, Liu Ye, Yi-Meng Zhang, Li-Jun Liang, Yan-Fei Zhang, Yi-Shuai Tan, Aikede Alifu, Meng-Yao Lv, Fen-Rong Xie, Yan-Yun Gao, Jiao-Jiao Xu, Yang-Tong Liu, Cong Wang, Bing-Qing Xu, Yan-Zhi Bai, Zhi-Xiao Liao, Yu-Tao Liu, Gui-Zhen Wang, Guang-Biao Zhou","doi":"10.1016/j.canlet.2026.218967","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218967","url":null,"abstract":"<p><p>To determine the cancer-initiating activity of oncoprotein CIP2A, which is overexpressed in a majority of cancers and promotes cell growth by stabilizing MYC, we established an alveolar type 2 cell-specific CIP2A transgenic mouse line. Among 114 transgenic mice aged 12 months or older, 23 (20.2%) developed lung adenocarcinoma (LUAD)-like disease, significantly higher than in the control mice (3/63, 4.8%). Multi-omic studies revealed enrichment of the oxidative phosphorylation (OXPHOS) pathway in tumor tissues from transgenic mice. CIP2A upregulated phosphorylation of FOXO3A (p-FOXO3A S253) by inhibiting phosphatase PP2A-B56α and promoted FOXO3A mitochondrial translocation. CIP2A-FOXO3A reshaped mitochondrial morphology, activated mitochondrial DNA transcription, and enhanced complexes IV/V activities. OXPHOS inhibitor repressed CIP2A-induced cell proliferation and tumor growth. Moreover, tobacco carcinogens upregulated CIP2A and p-FOXO3A S253 and significantly increased cancer incidence in CIP2A-transgenic mice. These data indicate that CIP2A plays a critical role in mitochondrial regulation and represents a promising therapeutic target for LUADs lacking actionable driver mutations.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218967"},"PeriodicalIF":11.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-onset Pancreatic Neuroendocrine Tumors: Distinct and Age-Related Metabolic Profiles. 早发性胰腺神经内分泌肿瘤:不同的和年龄相关的代谢谱。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-10 DOI: 10.1016/j.canlet.2026.218959
Changhao Gao, Zhiyao Fan, Shuang Si, Jiankang Zhu, Shuaishuai Xu, Qingdi Qin, Runxian Wang, Zhenya Liu, Boyu Diao, Yingmin Lin, Jianxiong Zhao, Shujie Liu, Bohan Su, Bin Zhou, Hanxiang Zhan
{"title":"Early-onset Pancreatic Neuroendocrine Tumors: Distinct and Age-Related Metabolic Profiles.","authors":"Changhao Gao, Zhiyao Fan, Shuang Si, Jiankang Zhu, Shuaishuai Xu, Qingdi Qin, Runxian Wang, Zhenya Liu, Boyu Diao, Yingmin Lin, Jianxiong Zhao, Shujie Liu, Bohan Su, Bin Zhou, Hanxiang Zhan","doi":"10.1016/j.canlet.2026.218959","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218959","url":null,"abstract":"<p><p>Early-onset pancreatic neuroendocrine tumors (EO-PanNETs) exhibit distinct clinical features, but their metabolic profiles and age-related associations remain poorly understood. This study included 641 patients with PanNETs from four tertiary centers in China. EO-PanNETs were defined as PanNETs diagnosed before 50 years. 1,282 hospital-based nonmalignant controls were matched 1:2 by age and sex. Conditional logistic regression and Cox models were used to assess associations with PanNET occurrence and survival outcomes, respectively. Age-related effect modification was assessed using exposure-by-age interaction terms, with age modeled continuously using restricted cubic splines (RCS) in sensitivity analyses. Compared with late-onset cases, EO-PanNETs exhibited a higher prevalence of reduced high-density lipoprotein cholesterol (29.2% vs 17.8%, P < 0.001). Although the overall prevalence of diabetes was similar between EO-PanNETs and LO-PanNETs, the proportion of new-onset cases among patients with diabetes was higher in EO-PanNETs(71.4% vs. 44.8%, P = 0.018). In case-control analyses using matched nonmalignant controls as reference, alcohol intake (OR, 1.77 vs. 0.79; P <sub>interaction</sub> = 0.008), diabetes mellitus (OR, 9.72 vs. 3.34; P <sub>interaction</sub> = 0.048) and elevated triglycerides (OR, 1.75 vs. 1.01; P <sub>interaction</sub> = 0.023) showed stronger associations with PanNET occurrence in younger individuals. EO-PanNETs also exhibited better overall survival and progression-free survival than LO-PanNETs. RCS analyses further identified age-related differences in the associations of alcohol intake and overweight with PanNET occurrence. These findings highlight age-related differences in the associations of metabolic factors with PanNETs, providing new insights into age-related metabolic heterogeneity in this rare disease.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218959"},"PeriodicalIF":11.8,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective Targeting of p53-Mutant Colorectal and Pancreatic Cancers by Combinatorial Therapeutic Strategy. 通过组合治疗策略有效靶向p53突变的结直肠癌和胰腺癌
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-09 DOI: 10.1016/j.canlet.2026.218962
Mohammed M Alruwaili, Yanqi Guo, Justin Zonneville, Thomas Melendy, Robert M Straubinger, Barbara A Foster, Priyanka Rajan, Henry Withers, Sarah Chatley, Renuka Iyer, Christos Fountzilas, Andrei V Bakin
{"title":"Effective Targeting of p53-Mutant Colorectal and Pancreatic Cancers by Combinatorial Therapeutic Strategy.","authors":"Mohammed M Alruwaili, Yanqi Guo, Justin Zonneville, Thomas Melendy, Robert M Straubinger, Barbara A Foster, Priyanka Rajan, Henry Withers, Sarah Chatley, Renuka Iyer, Christos Fountzilas, Andrei V Bakin","doi":"10.1016/j.canlet.2026.218962","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218962","url":null,"abstract":"<p><p>Existing treatment options for colorectal and pancreatic cancers harboring mutant p53 (p53<sup>mut</sup>) are largely ineffective and lack selectivity. Our novel therapeutic strategy for p53<sup>mut</sup> cancers with a thymidine analogue (TAS102) and a PARP inhibitor (PARPi) showed promising efficacy in a clinical trial, although the mechanisms remain not fully understood. Here, we investigated the molecular mechanisms underlying therapeutic efficacy of our approach and explored new combinations to further enhance the response. To define the contribution of each drug into the therapeutic response, we conducted an unbiased transcriptomic analysis in p53-proficient and p53<sup>mut</sup> cancer models. The biological effects were investigated in comprehensive analyses of cell proliferation, cell death, and DNA damage. The drug interactions were explored in cytotoxicity assays and efficacy was tested in patient-derived colorectal and pancreatic cancer models. We found that TAS102-PARPi treatment induces DNA breaks and long G2-arrest in p53<sup>mut</sup> cells, whereas normal cells rapidly repair their DNA and re-enter the cell cycle. Transcriptomic analysis showed that TAS102 is the major driver of the response, whereas PARPi improves selectivity of the TAS102 effects. The treatment does not block replication in p53<sup>mut</sup> cells but induces post-replicative DNA repair and represses mitosis. Delayed blockade of G2-checkpoint results in massive cell death in p53<sup>mut</sup> cells selectively. Priming TAS102-PARPi treatment in combination with delayed G2-checkpoint blockade was highly effective against cancer models and was well-tolerated in mice. Broadly, a novel two-step therapeutic strategy showed high efficacy and selectivity for p53<sup>mut</sup> cancers and low toxicity to normal tissues, demonstrating potential for clinical translation.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218962"},"PeriodicalIF":11.8,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atovaquone impedes muscle wasting in pancreatic cancer by AMPK modulation. 阿托伐醌通过AMPK调控抑制胰腺癌的肌肉萎缩。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-07 DOI: 10.1016/j.canlet.2026.218951
Somsekhara Derangula, Pradip Kumar Jaiswara, Anupam Mandal, Ravi Thakur, Woncheol Jung, Chao Xu, Tae Gyu Oh, Kamiya Mehla, Pankaj K Singh, Surendra K Shukla
{"title":"Atovaquone impedes muscle wasting in pancreatic cancer by AMPK modulation.","authors":"Somsekhara Derangula, Pradip Kumar Jaiswara, Anupam Mandal, Ravi Thakur, Woncheol Jung, Chao Xu, Tae Gyu Oh, Kamiya Mehla, Pankaj K Singh, Surendra K Shukla","doi":"10.1016/j.canlet.2026.218951","DOIUrl":"10.1016/j.canlet.2026.218951","url":null,"abstract":"<p><p>Cancer-induced cachexia is a multifactorial syndrome characterized by systemic inflammation and progressive skeletal muscle and fat wasting. More than 80% pancreatic cancer patients exhibit a cachectic phenotype, which significantly contributes to the overall mortality of cancer patients. Till now, there is no FDA-approved therapy for cancer-associated cachexia that has been developed. In the present study, we have demonstrated the anti-cachectic potential of an anti-malarial compound, atovaquone. We observed that atovaquone inhibits cancer cell-conditioned media-induced myotube atrophy in a dose-dependent manner. Atovaquone treatments lead to reduced cachectic markers expression in conditioned media-treated myotubes. Further, we observed that atovaquone treatment results in reduced reactive oxygen species levels in conditioned media-treated myotubes. Mechanistically, we observed that atovaquone treatment of myotubes enhances the glycolytic capacity of conditioned-media-treated myotubes by upregulating Glut4 expression. Furthermore, we established that increased Glut4 expression is primarily driven by atovaquone-induced AMPK activation. By utilizing a syngeneic orthotopic implantation model of pancreatic cancer, we have observed that atovaquone can inhibit cachectic phenotype in tumor-bearing mice, without impacting the overall tumour growth. Overall, we have demonstrated that atovaquone exhibits anti-cachectic properties in both in vitro and in vivo model systems of pancreatic cancer-associated cachexia by modulating glycolytic capacity.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218951"},"PeriodicalIF":11.8,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma. 代谢应激将DHODH从肿瘤发生到slc7a11驱动的食管鳞状细胞癌的双重下垂和放射致敏。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-06 DOI: 10.1016/j.canlet.2026.218958
Xin Li, Yenan Wu, Minyi Lu, Wenyan Gao, Mengmeng Lu, Yaoyi Zhu, Yongling Ji, Zhihua Liu, Aiping Luo
{"title":"Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma.","authors":"Xin Li, Yenan Wu, Minyi Lu, Wenyan Gao, Mengmeng Lu, Yaoyi Zhu, Yongling Ji, Zhihua Liu, Aiping Luo","doi":"10.1016/j.canlet.2026.218958","DOIUrl":"10.1016/j.canlet.2026.218958","url":null,"abstract":"<p><p>Metabolic plasticity enables tumors to adapt to fluctuating nutrient environments, yet the non-canonical functions of metabolic enzymes under stress remain largely unexplored. Here, we established a pyrimidine biosynthesis-associated gene score (PBAGS) that predicts survival in esophageal squamous cell carcinoma (ESCC) and identified dihydroorotate dehydrogenase (DHODH) as a critical driver with a context-dependent dual role. Under glucose-replete conditions, DHODH functions as a canonical oncogene, promoting pyrimidine and cysteine metabolism, alongside UDP-GlcNAc production; accordingly, its inhibition by leflunomide suppresses tumor growth. Strikingly, under glucose starvation, DHODH undergoes a functional switch to become a \"molecular executioner.\" Mechanistically, starvation triggers the DHODH-OGT axis to maintain site-specific O-GlcNAcylation of SLC7A11 at Ser26, thereby stabilizing SLC7A11. This modification promotes excessive cystine accumulation and subsequent actin cytoskeleton collapse, ultimately triggering disulfidptosis. Accordingly, inhibition of DHODH abolishes this modification and rescues cells from starvation-induced death. Clinically, DHODH-SLC7A11 axis correlates tightly with GLUT1 expression. Mimicking glucose starvation using GLUT1 inhibitor BAY-876 significantly enhances radiosensitivity in ESCC PDX models that harbor high DHODH/SLC7A11 expression. Collectively, our findings uncover that under glucose starvation, DHODH and SLC7A11 co-dependency synergistically promotes disulfidptosis, suggesting that targeting the metabolic context offers a potent strategy to sensitize ESCC to radiotherapy.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218958"},"PeriodicalIF":11.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crosstalk Between RARγ-Driven Tumor Cells and Cancer-Associated Fibroblasts Governs Ferroptosis Resistance in Cholangiocarcinoma. rar γ驱动的肿瘤细胞和癌相关成纤维细胞之间的串扰影响胆管癌对铁的抵抗。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-06 DOI: 10.1016/j.canlet.2026.218947
Si-Yang Li, Fa-Hui Liu, Jin Shang, Hui-Qi Li, Rui-Han Li, Jia-Nan Wang, Peng Xu, Hao-Xuan Zhang, Xiao-Yun Zhang, Dong-Hua Liu, Shi-Hang Tang, Fu-Xing Zhang, Dong-Yan Shen
{"title":"Crosstalk Between RARγ-Driven Tumor Cells and Cancer-Associated Fibroblasts Governs Ferroptosis Resistance in Cholangiocarcinoma.","authors":"Si-Yang Li, Fa-Hui Liu, Jin Shang, Hui-Qi Li, Rui-Han Li, Jia-Nan Wang, Peng Xu, Hao-Xuan Zhang, Xiao-Yun Zhang, Dong-Hua Liu, Shi-Hang Tang, Fu-Xing Zhang, Dong-Yan Shen","doi":"10.1016/j.canlet.2026.218947","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218947","url":null,"abstract":"<p><p>Cholangiocarcinoma (CCA) is characterized by a dense desmoplastic microenvironment dominated by cancer-associated fibroblasts (CAFs), which profoundly shape tumor behavior and diminish therapeutic efficacy. By integrating analyses of patient specimens with multi-omics profiling, mechanistic assays, tumor-CAF co-culture and xenograft models, and single-cell transcriptomics, we identified retinoic acid receptor γ (RARγ) as a central regulator of reciprocal communication between malignant cells and CAFs that promotes ferroptosis resistance. RARγ was markedly elevated in CAF-enriched tumors and associated with poor overall survival. Multi-omics integration revealed that RARγ increases CREB stability and reduces K33- and K48-linked polyubiquitination, thereby enhancing CREB occupancy at the AKR1C1 promoter and driving transcriptional activation. AKR1C1 subsequently reinforces the Nrf2-GPX4 antioxidant axis, elevates glutathione metabolism, and suppresses lipid peroxidation. Beyond intrinsic protection, RARγ induces LCN2 transcription and promotes exosomal packaging of LCN2, which is transferred to adjacent CAFs and triggers robust CSF3 (G-CSF) secretion. CAF-derived G-CSF feeds back to malignant cells to amplify RARγ expression and ferroptotic tolerance, forming a self-sustaining paracrine circuit. Single-cell RNA sequencing further supported coordinated interactions between RARG<sup>+</sup> tumor subsets and CSF3<sup>+</sup> CAFs, reinforcing the relevance of this signaling loop in human CCA. Collectively, these findings position RARγ as a master organizer of tumor-stroma crosstalk through the CREB-AKR1C1 and LCN2-CSF3 axes, establishing a ferroptosis-resistant niche and promoting CCA aggressiveness.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218947"},"PeriodicalIF":11.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The metabolic dependency on GLUT3 mediates smoking-induced NSCLC progression. 对GLUT3的代谢依赖介导吸烟诱导的非小细胞肺癌进展。
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-05 DOI: 10.1016/j.canlet.2026.218945
Fang-Ju Cheng, Yi-Cheng Shen, Bo-Rong Chen, Shu-Wei Hu, Le Huynh Hoai Thuong, Ya-Ling Wei, Yu-Hao He, Yi-Lun Yeh, Ting-Wei Zhang, I-Shan Hsieh, Ting-Yi Ko, Yang-Chang Wu, Jin-Cherng Lien, Yi-Chuan Li, Der-Yen Lee, Chia-Hung Chen, Chih-Yen Tu, Miaw-Ling Chen, Novelyn Putri Kinanti, Yuki Sugiura, Baihao Zhang, Masaki Tajima, Sidonia Fagarasan, Mien-Chie Hung, Chih-Hsin Tang, Wei-Chien Huang
{"title":"The metabolic dependency on GLUT3 mediates smoking-induced NSCLC progression.","authors":"Fang-Ju Cheng, Yi-Cheng Shen, Bo-Rong Chen, Shu-Wei Hu, Le Huynh Hoai Thuong, Ya-Ling Wei, Yu-Hao He, Yi-Lun Yeh, Ting-Wei Zhang, I-Shan Hsieh, Ting-Yi Ko, Yang-Chang Wu, Jin-Cherng Lien, Yi-Chuan Li, Der-Yen Lee, Chia-Hung Chen, Chih-Yen Tu, Miaw-Ling Chen, Novelyn Putri Kinanti, Yuki Sugiura, Baihao Zhang, Masaki Tajima, Sidonia Fagarasan, Mien-Chie Hung, Chih-Hsin Tang, Wei-Chien Huang","doi":"10.1016/j.canlet.2026.218945","DOIUrl":"https://doi.org/10.1016/j.canlet.2026.218945","url":null,"abstract":"<p><p>Cigarette smoking is strongly associated with aggressive non-small cell lung cancer (NSCLC), yet the mechanisms linking smoke exposure to metabolic reprogramming remain incompletely understood. Here, we integrated clinical, molecular, and functional analyses to define a smoking-associated metabolic axis in NSCLC. Lung cancer patients with a smoking history exhibited significantly higher tumor <sup>18</sup>F-FDG uptake than never-smokers, suggesting an association between smoking exposure and increased tumor metabolic activity. Consistently, chronic exposure of NSCLC cells to cigarette smoke extract (CSE) or its ingredient benzo[α]pyrene (B[α]P) increased glucose uptake, glycolysis, ATP production, and malignant phenotypes, including proliferation, migration, and sphere formation. Mechanistically, GLUT3 protein, but not mRNA, was selectively upregulated in smoke-exposed tumors and cell models, suggesting post-transcriptional regulation. We identified miR-146a as a direct suppressor of GLUT3 through binding to its 3'UTR and found that cigarette smoke markedly reduced miR-146a expression. Smoker-derived NSCLC tumors exhibited lower miR-146a expression and higher GLUT3 levels, which were inversely correlated and associated with poor overall survival. Restoration of miR-146a reduced GLUT3 expression, glucose uptake, and tumor cell proliferation, supporting a central role for the miR-146a/GLUT3 axis in smoking-induced metabolic reprogramming. (-)Gallocatechin ((-)GC), a naturally occurring catechin, is further identified as a selective GLUT3 inhibitor and suppressed smoke-induced glucose uptake, tumor progression, and metastasis without detectable systemic toxicity. Collectively, these findings identify the miR-146a/GLUT3 axis as a key mechanism underlying smoking-driven metabolic reprogramming and establish GLUT3 as a potential metabolic target in NSCLC and other GLUT3-dependent malignancies.</p>","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218945"},"PeriodicalIF":11.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on the Chinese guidelines for the diagnosis and treatment of pediatric craniopharyngioma (2025). 《中国儿童颅咽管瘤诊疗指南(2025)》述评
IF 11.8 1区 医学
Cancer letters Pub Date : 2026-11-05 DOI: 10.1016/j.canlet.2026.218952
Ao Chen, Yiguang Chen, JianJian Zhang
{"title":"Comment on the Chinese guidelines for the diagnosis and treatment of pediatric craniopharyngioma (2025).","authors":"Ao Chen, Yiguang Chen, JianJian Zhang","doi":"10.1016/j.canlet.2026.218952","DOIUrl":"10.1016/j.canlet.2026.218952","url":null,"abstract":"","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":" ","pages":"218952"},"PeriodicalIF":11.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书